A recent study published in the Journal of the National Cancer Institute found that nearly a third of British adult survivors of childhood cancer have been regular smokers at some point in their lives. Smoking is an additional source of risk for this population due to long-term effects of original cancer and treatment, as well as genet...
A study comparing two breast cancer screening strategies in Norway and Vermont found that both approaches were equally sensitive for detecting cancer, with similar age-adjusted screening detection rates. However, the recall rate for abnormal mammograms was lower in Norway, while the rate of interval cancers was higher in Vermont.
A new study finds that patient age, predisposition to heart disease, and prior treatments are associated with an individual's risk of developing heart problems following epirubicin treatment. The researchers recommend lowering the cumulative dose recommended for most patients, with maximum doses ranging from 300 mg/m2 to 900 mg/m2.
Researchers found that adding single nucleotide polymorphisms (SNPs) to clinical models did not significantly improve the accuracy of breast cancer risk predictions. In fact, SNPs were less able to accurately discriminate risk than established models using clinical factors.
Researchers found that reducing iron blood levels in men with peripheral arterial disease is associated with a decreased incidence of cancer. The study, published in the Journal of the National Cancer Institute, suggests that iron catalyzes the production of free radicals that damage cellular components, including DNA.
A commentary discusses common pitfalls of epidemiological research that lead to false-positive results, including chance, systematic errors, and inadequate accounting for confounding variables. To mitigate these issues, researchers should use more rigorous methods and evaluate results critically.
A study published in the Journal of the National Cancer Institute found that higher education levels were associated with significant mortality reductions in four common cancers: lung, colorectal, prostate, and breast. Individuals with a college degree experienced greater declines in cancer mortality rates compared to those with less e...
Researchers found that LYN kinase activation is associated with imatinib resistance in CML patients, a mechanism not explained by BCR-ABL mutations. Blocking LYN kinase restores imatinib responsiveness and triggers cell death.
Researchers identified CHD5 as a tumor suppressor gene associated with better outcomes in neuroblastoma patients. Intestinal proteins were found to be effective anti-tumor antigens in mice, potentially reducing autoimmune complications.
A study found that certain mammography facility characteristics, such as breast imaging specialists and screening/diagnostic services, are associated with improved interpretive accuracy. The analysis of 44 facilities performed over 484,463 screenings revealed variations in cancer detection rates between locations.
A novel small molecule inhibitor reduced both endogenous and drug-induced resistance to chemotherapy in a mouse model of melanoma. Low melatonin levels are associated with an increased risk of breast cancer in postmenopausal women, according to a prospective case-control study.
The updated charts show a person's risk of dying from a given cause within the next 10 years, taking into account their age, sex, and smoking status. The charts provide two key elements: the magnitude of the risk and context to help people understand where to focus risk reduction efforts.
A randomized controlled trial found that raloxifene reduced the risk of invasive ER-positive breast cancer by 44% in postmenopausal women. The drug did not affect non-invasive cancers or those with osteoporosis without high breast cancer risk.
The cost of cancer care for elderly patients in the US increased significantly between 1991 and 2002 due to rising costs of radiation therapy and chemotherapy. The average cost per patient for lung, colorectal, and breast cancers rose substantially during this period.
Researchers reviewing randomized trials found that antioxidant supplementation may reduce overall survival in patients receiving radiotherapy. Conversely, no clear evidence suggests that antioxidant treatment increases tumor response rates during chemotherapy.
Researchers analyzed vitamin D concentrations in 749 men with prostate cancer and 781 without, finding no correlation between vitamin D levels and prostate cancer risk. However, higher vitamin D levels were associated with increased risks of aggressive disease, but the association was not statistically significant.
Studies found that mutations in the p14ARF gene can promote melanoma development, even with normal p16 levels. Researchers also discovered an estrogen signaling pathway in aggressive prostate cancer, driving its growth. Additionally, adding paclitaxel to standard chemotherapy improves outcomes in early breast cancer patients.
Women with a sister diagnosed with breast cancer face an increased risk of developing the disease throughout their lives. Regular exercise during adolescence and young adulthood is associated with a lower risk of premenopausal breast cancer. Meanwhile, disparities in rectal cancer outcomes persist despite access to oncologists, highlig...
A meta-analysis found that PET imaging failed to identify 50% of occult lesions in clinically node-negative patients, while incorrectly identifying normal tissue as cancerous 13% of the time. The study suggests that FDG-PET may not improve diagnostic accuracy for early head and neck cancer
A new study published in the Journal of the National Cancer Institute estimates that Medicare costs for elderly cancer patients will top $21.1 billion over a 5-year period. The estimated cost varies widely depending on tumor type, stage at diagnosis, and phase of care.
A mathematical model suggests that women with wild-type CYP2D6 genotype may derive as much benefit from tamoxifen as from aromatase inhibitors, potentially leading to personalized therapy approaches. Additionally, a study finds that cancer stem cells resistant to standard chemotherapy are responsive to targeted therapy.
A nationwide study found that regular cervical cancer screening reduces incidence rates in all ages, particularly among younger women. However, imperfect population coverage and inadequate follow-up programs remain major risk factors, highlighting the need for improved screening programs.
A randomized controlled trial found that conjugated equine estrogen increased the risk of benign proliferative breast disease by more than two-fold. Women taking estrogen supplements had 155 cases of benign disease compared to 77 in the placebo group.
Recent studies suggest that preoperative chemotherapy can be effective in early breast cancer treatment, but individual responses may vary. Additionally, a case-control study found no increased risk of cancer among frequent blood donors. Furthermore, researchers have identified a novel mechanism to overcome resistance to targeted thera...
A randomized controlled trial found that high-dose chemotherapy did not increase survival rates for patients with small cell lung cancer. Despite increased tumor shrinkage, the high-intensity approach was deemed ineffective and highly toxic.
The use of sentinel lymph node biopsy (SLNB) increased substantially from 1998 to 2005, but disparities persist in access to the procedure. Non-white women, older women, and those living in poorer areas were less likely to receive SLNB than their counterparts, highlighting uneven access to this less-invasive breast cancer staging test.
A study examined 75 group-randomized oncology trials and found a substantial number of problems with the trials. Many relied on analyses that ignored group randomization altogether, raising concerns about type I errors. In contrast, HPV-based screening was found to be more accurate in detecting cervical precancerous lesions than cytology.
A new study has found that hormone replacement therapy (HRT) increases the risk of breast cancer recurrence in women who have survived breast cancer. The HABITS trial, which followed over 200 breast cancer survivors for four years, found that HRT significantly increased the risk of disease recurrence.
A randomized clinical trial found that postoperative chemotherapy does not improve survival in patients with localized gastric cancer. Despite promising results in advanced gastric cancer, the combination of cisplatin, epirubicin, and other chemotherapies did not show significant benefits.
A study of Hiroshima and Nagasaki bombing survivors found that radiation exposure in utero and early childhood increases the risk of adult solid cancers. Individuals carrying a rare genetic variant of AKAP9 gene also have an increased risk of breast cancer.
A nationwide study in the Netherlands found that women diagnosed with early-stage ovarian cancer treated at semispecialized or specialized hospitals survived longer than those treated at general hospitals. The estimated five-year survival improved with increasing specialization of the treatment facility, from 38% to 40.3%.
A study of 829 Canadian women diagnosed with early breast cancer found that they lost an average of 27% of their typical income during the first 12 months after diagnosis. The researchers also discovered that wage losses were more common among less educated women, those with more serious disease, and those with less social support.
A large randomized trial of personalized interventions found that two behavioral interventions did not significantly increase regular mammograms in female veterans. The study's findings support the generalizability to the US female population, which has seen a decline in mammography rates. Meanwhile, another study suggests that viral D...
A study found that 46% of patients received a maximum dose above 10% beyond the prescribed level, while 63% got a minimum dose below 10%, highlighting the need for standardization in intensity-modulated radiation therapy.
A study found that breast cancer survivors, especially older women, are at a greater risk of dying from non-cancer causes than from breast cancer. Factors such as pre-existing diseases like heart disease and osteoporosis are associated with this increased risk. The researchers also found that women with cancer cells in the lymph nodes ...
A study published in the Journal of the National Cancer Institute found that HPV-positive head and neck cancer patients have higher response rates to chemoradiation therapy and better two-year overall survival rates compared to HPV-negative patients.
A study found that women with ductal carcinoma in situ (DCIS) have overly optimistic views of their risk of recurrence and invasive breast cancer. Anxiety levels decreased over time, but depression remained low. Clinicians should be aware of these inaccurate perceptions to minimize distress.
A collaborative analysis of 18 prospective studies found no link between circulating sex hormones and prostate cancer risk. High levels of male sex hormones were previously thought to be a risk factor, but the results indicate that testosterone and estrogen do not play a significant role in prostate cancer development.
Researchers found Ki-67 expression associated with poorer disease-free survival, but not predictive of chemotherapy benefit. Pathology reports offer a reliable alternative for determining ER status in breast cancer trials.
Researchers analyzed data from nearly 30,000 women with breast cancer and found that female surgeons were more likely to prescribe post-surgical radiation therapy. Women who received radiation had a surgeon trained in the US or with an M.D. degree compared to a D.O. degree.
Researchers have developed a new method for presenting clinical trial survival data that includes all participants, overcoming the limitations of traditional Kaplan-Meier plots. This new approach provides a more accurate representation of treatment effects, enabling physicians and patients to better understand clinical trial results.
Researchers found patients taking statins had a lower incidence of cancer compared to non-statin users. Additionally, a new receptor may be targeted for colon cancer treatment, while a mouse model of rare kidney disorder shows promise for studying cancer development.
A randomized clinical trial found that adding docetaxel to anthracycline-based chemotherapy improved disease-free survival in breast cancer patients. The study showed a 4% increase in five-year disease-free survival rates, with patients receiving sequential docetaxel after doxorubicin having the best outcomes.
The study found that anthracycline-based chemotherapy improves disease-free and overall survival rates more than non-anthracycline-based regimens for women with HER2-positive tumors. However, the treatment showed no significant benefit for patients with HER2-negative breast cancer.
Cancer risk increases with age, yet elderly nursing home residents receive relatively few cancer care services. According to a recent study, only 28% of patients with late-stage cancer received hospice care, highlighting the need for further investigation into cancer care in this population.
Breast cancer patients who received tamoxifen or chemotherapy had a reduced risk of developing a second cancer in the other breast. Chemotherapy was associated with a 43% risk reduction, lasting up to 10 years, while tamoxifen use resulted in a 34% risk reduction that persisted for five years.
A study published in the Journal of the National Cancer Institute found that diagnostic mammogram readings vary extensively by radiologist, with no explanation for the variation. Radiologists' performance was influenced by their experience, affiliation, and time spent interpreting mammograms.
A recent study found that postmenopausal women taking anastrozole after tamoxifen treatment had a 38% reduced risk of breast cancer recurrence. Additionally, research indicates that blood transfusions may slightly increase cancer risk in the months following the procedure, likely due to underlying undiagnosed cancer.
Researchers identified a variant of the tumor suppressor gene DAB2IP associated with aggressive prostate cancer. A study of nearly 1,000 Swedish men and two independent groups confirmed the link, suggesting this gene plays a role in prostate cancer progression.
A new risk prediction model for African American women has been developed and tested, providing more accurate estimates of breast cancer risk compared to the widely used Gail model. The model, known as CARE, accurately predicted the number of cancers observed in African American women in most subgroups.